Abstract
Abstract
This study examines the role of host inflammation in the high mortality of tuberculous meningitis (TBM) and identifies potential biomarkers associated with improved survival. We conducted a case-control study involving 131 patients in a discovery cohort, 81 TBM patients in a validation cohort, and 43 non-infected controls from a referral hospital in Indonesia. We measured 94 inflammation-related proteins in cerebrospinal fluid (CSF) and performed genome-wide quantitative trait loci (QTL) mapping. Sixty-seven proteins were found to be differentially expressed between TBM patients and controls, with 64 proteins elevated in patients. Five proteins, including vascular endothelial growth factor (VEGF) and matrix metalloproteinase-10 (MMP-10), were identified as predictors of 180-day mortality in TBM patients. The validation cohort confirmed that MMP-10, but not VEGF, was predictive of mortality. Genome-wide QTL mapping identified two genome-wide significant and four suggestive genetic loci associated with CSF MMP-10, which also predicted survival in an additional cohort of 218 patients. High CSF concentrations of MMP-10, along with specific genetic loci, may be associated with survival in TBM patients, suggesting a potential role for MMP-10 in disease pathogenesis and warranting further investigation into its utility in host-directed therapies.
Topics

No keywords indexed for this article. Browse by subject →

References
24
[1]
Thwaites "Tuberculous meningitis: More questions, still too few answers" Lancet Neurol (2013) 10.1016/s1474-4422(13)70168-6
[2]
Tuberculous meningitis

Robert J. Wilkinson, Ursula Rohlwink, Usha Kant Misra et al.

Nature Reviews Neurology 2017 10.1038/nrneurol.2017.120
[3]
Prasad "Corticosteroids for managing tuberculous meningitis" Cochrane Database Syst Rev (2016)
[4]
Thuong "Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis" J Infect Dis (2017) 10.1093/infdis/jix050
[5]
Simmons "Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: Diagnostic value and relationship to disease severity and outcome" J Immunol (2006) 10.4049/jimmunol.176.3.2007
[6]
Van Laarhoven "Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in Indonesia" J Infect Dis (2017) 10.1093/infdis/jix051
[7]
Rohlwink "Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies" Wellcome Open Res (2020) 10.12688/wellcomeopenres.15497.2
[8]
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

Erika Assarsson, Martin Lundberg, Göran Holmquist et al.

PLoS ONE 2014 10.1371/journal.pone.0095192
[9]
van Laarhoven "Cerebral tryptophan metabolism and outcome of tuberculous meningitis: An observational cohort study" Lancet Infect Dis (2018) 10.1016/s1473-3099(18)30053-7
[10]
Ardiansyah "Sequencing whole genomes of the West Javanese population in Indonesia reveals novel variants and improves imputation accuracy" Front Genet (2025) 10.3389/fgene.2024.1492602
[11]
Rohlwink "Biomarkers of brain injury in cerebral infections" Clin Chem (2014) 10.1373/clinchem.2013.212472
[12]
Svensson "Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculous meningitis trials" Clin Infect Dis (2020) 10.1093/cid/ciz1071
[13]
Ward "HaploReg v4: Systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease" Nucleic Acids Res (2016) 10.1093/nar/gkv1340
[14]
Rodriguez "Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli" Front Biosci (2008) 10.2741/2896
[15]
Brilha "Early secretory antigenic target-6 drives matrix metalloproteinase-10 gene expression and secretion in Tuberculosis" Am J Respir Cell Mol Biol (2017) 10.1165/rcmb.2016-0162oc
[16]
Jenner "Insights into host responses against pathogens from transcriptional profiling" Nat Rev Microbiol (2005) 10.1038/nrmicro1126
[17]
Marais "Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome" Clin Infect Dis (2014) 10.1093/cid/ciu641
[18]
Rohlwink "Matrix metalloproteinases in pulmonary and central nervous system Tuberculosis-A review" Int J Mol Sci (2019) 10.3390/ijms20061350
[19]
Brilha "Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis" Sci Rep (2017) 10.1038/s41598-017-16250-3
[20]
Green "Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks" J Immunol (2010) 10.4049/jimmunol.0903811
[21]
Green "Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis" PLoS One (2009) 10.1371/journal.pone.0007277
[22]
Figaji "The neurosurgical and acute care management of tuberculous meningitis: Evidence and current practice" Tuberculosis (Edinb) (2010) 10.1016/j.tube.2010.09.005
[23]
Te Brake "Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis" Int J Antimicrob Agents (2015) 10.1016/j.ijantimicag.2014.12.027
[24]
Ruslami "Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: An open-label, randomised controlled phase 2 trial" Lancet Infect Dis (2013) 10.1016/s1473-3099(12)70264-5
Metrics
5
Citations
24
References
Details
Published
Jan 01, 2025
Vol/Issue
7(4)
License
View
Authors
Funding
National Institutes of Health
European Research Council Award: #833247
United States Agency for International Development
Direktorat Jenderal Pendidikan Tinggi
Netherlands Foundation for Scientific Research Award: 017.106.310
Using Tryptophan Metabolism and Response to Corticosteroids to Define New Therapeutic Targets for Tuberculosis Meningitis: Integration of Large Scale Clinical, Metabolomic, and Genomic Data Award: R01AI145781
INtegrative omics and aspirin response to define ThERapeutiC targEts for Pediatric Tbm Award: R01AI165721
Cite This Article
Sofiati Dian, Valerie A C M Koeken, Edwin Ardiansyah, et al. (2025). Inflammatory markers in the cerebrospinal fluid linked to mortality in tuberculous meningitis. Brain Communications, 7(4). https://doi.org/10.1093/braincomms/fcaf273